Release Date: 30/04/20 14:11 Summary: Resignation of Managing Director Price Sensitive: Yes Download Document 122.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%